Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Available until 8/1/2024

Welcome to PracticeUpdate! We hope you are enjoying access to a selection of our top-read and most recent articles. Please register today for a free account and gain full access to all of our expert-selected content.

Already Have An Account? Log in Now

Journal Scan / Research · May 20, 2024

Effect of Melatonin Supplementation on the Risk of Type 2 Diabetes and CVD

The Lancet Diabetes & Endocrinology




This abstract is available on the publisher's site.

Access this abstract now  

Additional Info

The Lancet Diabetes & Endocrinology
Use of melatonin supplements and risk of type 2 diabetes and cardiovascular diseases in the USA: insights from three prospective cohort studies
Lancet Diabetes Endocrinol 2024 May 03;[EPub Ahead of Print], Y Li, T Huang, S Redline, et al

Further Reading